In recent years, there has been considerable interest in the study of the relationship of serum cholesterol with cancer incidence and mortality (Hlatky & Hulley, 1981; Levy, 1982; Feinleib, 1983;McMichael et al., 1984). A number of studies have shown an inverse association in men, though usually not in women, whereas in other reports there was no relationship. The most consistent (inverse) association was for cancer of the colon. Two population-based prospective studies in Israel, the Kiryat Hayovel Community Health Study in Jerusalem and the Israel Ischemic Heart Disease Study showed higher levels of serum cholesterol (with mean differences of about 20 mg dl-1 and 16 mg dl1 respectively) in the small numbers (5 and 17 respectively) of subjects who died of intracranial tumours during follow-up (Kark et al. and Goldbourt et al., unpublished observations). A small case-control comparison showed substantially higher serum cholesterol levels in 7 hospitalized brain tumour patients than in hospitalized controls with a variety of debilitating diseases (Basu et al., 1974).The objective of our study was to test the hypothesis that a positive relationship exists between high levels of serum cholesterol and primary brain tumours (including meningeal tumours).
Subjects and methodsA case-control study was performed based on the hospital records of male Jewish residents of Israel [20][21][22][23][24], and of 10 years at older ages) and year of hospitalization. For two cases, controls were found only from the subsequent year. The controls for each case were chosen randomly from